– FRANCE, Paris – TISSIUM, a privately-owned MedTech company developing biomorphic programmable polymers for tissue reconstruction, today announced €50 million Series C financing from new and existing international investors.…
– IRELAND, Dublin – Mainstay Medical Holdings plc today announced the closing of US$108 million equity financing co-led by new investors Ally Bridge Group and Sofinnova Partners alongside a large, global medical device company and key existing investors also participating as Sofinnova Partners, KCK Group and Fountain Healthcare Partners.…
– SWITZERLAND, Basel – Noema Pharma AG, a Swiss clinical-stage company targeting orphan neurological disorders, today announced it has successfully concluded an oversubscribed Series A CHF54 million financing round co-led by Sofinnova Partners and Polaris Partners alongside a global consortium of new international investors includes Gilde Healthcare, Invus, and BioMed Partners.…
– USA, MA – Catamaran Bio, Inc., a biotechnology company developing allogeneic CAR-NK cell therapies to treat cancer, today announced that the company has launched with a $42 million financing, including a Series A round co-led by Sofinnova Partners and Lightstone Ventures alongside participation by founding investor SV Health Investors, as well as Takeda Ventures and Astellas Venture Management.…
– SWITZERLAND, Basel – Polyneuron Pharmaceuticals AG, a clinical-stage developer of a new class of antigen-specific polymers for the treatment of patients with serious autoimmune diseases, today announced a CHF 14 million extension of the Series A funding round led by Sofinnova Partners, and which included HBM Healthcare Investments, New Enterprise Associates and other private investors, bringing the total funding to date to CHF 36.5 million.…
